Atrial Fibrillation and Risk of ST-Segment–Elevation Versus Non–ST-Segment–Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study
暂无分享,去创建一个
Mary Cushman | Elsayed Z Soliman | L. Chen | E. Soliman | M. Cushman | Á. Alonso | L. Loehr | Wesley T. O’Neal | Lin Y Chen | Alvaro Alonso | Zhu-Ming Zhang | Laura Loehr | Faye Lopez | Wesley T O'Neal | Lindsay Bengtson | Faye L. Lopez | Zhu-ming Zhang | L. Bengtson | Á. Alonso | Á. Alonso
[1] Stephen S. Cha,et al. Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.
[2] Timothy Watson,et al. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.
[3] Ronald J. Prineas,et al. The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .
[4] D. Knopman,et al. The Metabolic Syndrome and Cognitive Decline in the Atherosclerosis Risk in Communities Study (ARIC) , 2014, Dementia and Geriatric Cognitive Disorders.
[5] James Floyd,et al. A systematic review of validated methods for identifying atrial fibrillation using administrative data , 2012, Pharmacoepidemiology and drug safety.
[6] Elsayed Z Soliman,et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.
[7] C. Moy,et al. The Sensitivity of the Method Used to Detect Atrial Fibrillation in Population Studies Affects Group-Specific Prevalence Estimates: Ethnic and Regional Distribution of Atrial Fibrillation in the REGARDS Study , 2009, Journal of epidemiology.
[8] P. Vardas,et al. Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. , 2007, The American journal of cardiology.
[9] A. Folsom,et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. , 2003, Journal of clinical epidemiology.
[10] G. Lip,et al. Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.
[11] M. Russo,et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.
[12] A. Folsom,et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. , 1996, Journal of clinical epidemiology.
[13] J. Carrero,et al. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. , 2014, JAMA.
[14] G. Marcus,et al. Atrial fibrillation begets myocardial infarction. , 2014, JAMA internal medicine.
[15] Joel Stein,et al. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.
[16] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[17] J. Cook,et al. Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit , 2005, Annals of Internal Medicine.
[18] Sonia S Anand,et al. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. , 1999, JAMA.
[19] M Lunn,et al. Applying Cox regression to competing risks. , 1995, Biometrics.
[20] K. Toyama,et al. Endothelial dysfunction in paroxysmal atrial fibrillation as a prothrombotic state. Comparison with permanent/persistent atrial fibrillation. , 2011, Journal of atherosclerosis and thrombosis.
[21] Ralph B D'Agostino,et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. , 2003, JAMA.
[22] Zhu-ming Zhang,et al. Ethnic Distribution of ECG Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities (ARIC) Study , 2009, Stroke.
[23] E. Benjamin,et al. Status of the epidemiology of atrial fibrillation. , 2008, The Medical clinics of North America.
[24] V. Howard,et al. Racial Disparities in Awareness and Treatment of Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2010, Stroke.
[25] M. Hori,et al. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[26] Y. Kagaya,et al. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. , 2001, Journal of the American College of Cardiology.
[27] U. Goldbourt,et al. Long-term prognosis of patients after a Q wave compared with a non-Q wave first acute myocardial infarction. Data from the SPRINT Registry. , 1996, European heart journal.
[28] Christopher X. Wong,et al. Assessment of endothelial function in atrial fibrillation: utility of peripheral arterial tonometry , 2012, Clinical and experimental pharmacology & physiology.
[29] G. Hutchins,et al. Coronary artery embolism and myocardial infarction. , 1978, Annals of internal medicine.
[30] MattDewhurst,et al. Regarding Article “Ethnic Distribution of Electrocardiographic Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities Study (ARIC)” , 2011 .
[31] David M Herrington,et al. Atrial fibrillation and the risk of myocardial infarction. , 2015, JAMA internal medicine.
[32] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[33] A. Belanger,et al. The Framingham study. , 1976, British medical journal.
[34] Christopher X. Wong,et al. Atrial platelet reactivity in patients with atrial fibrillation. , 2010, Heart rhythm.
[35] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[36] S. Mondillo,et al. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. , 2000, International journal of cardiology.
[37] R. Califf,et al. Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent Ischemia , 1998 .
[38] Michael Abdelnoor,et al. Warfarin, aspirin, or both after myocardial infarction. , 2002, The New England journal of medicine.
[39] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[40] G. Lip,et al. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. , 1995, British heart journal.
[41] L. Chen,et al. Comparable Ascertainment of Newly-Diagnosed Atrial Fibrillation Using Active Cohort Follow-Up versus Surveillance of Centers for Medicare and Medicaid Services in the Atherosclerosis Risk in Communities Study , 2014, PloS one.
[42] K. Lee,et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. , 1998, Circulation.
[43] A. Folsom,et al. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). , 2008, The American journal of cardiology.
[44] P. Sanders,et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. , 2013, Journal of the American College of Cardiology.